<p>Pew's antibiotics and innovation project addresses the growing public health challenge of multidrug-resistant infections by supporting policies that stimulate and encourage the development of antibiotics to treat life-threatening illnesses.</p> http://www.pewtrusts.org/news_room.aspx <p>''Americans are not as smart about antibiotics and antibiotic resistance as they should be, a new poll shows. For instance, although almost 90 percent of Americans know that antibiotics are effective for treating bacterial infections, more than a third also erroneously believed the drugs can fight viral infections such as the common cold or the flu.''</p> Wed, 14 Nov 2012 16:05:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899430428&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=''Many Americans Still in the Dark About Antibiotic Resistance''&WT.z_contenttype=NewsArticle "And a new survey out today from the Pew Charitable Trusts and the U.S. Centers for Disease Control and Prevention (CDC) shows 79% of adults know they can harm their own health by taking unneeded antibiotics." Tue, 13 Nov 2012 15:55:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899430062&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=''Southeast paying health price for high antibiotic use''&WT.z_contenttype=NewsArticle Nearly nine in 10 Americans recognize that antibiotics are effective treatments for fighting bacterial infections like strep throat, but more than a third mistakenly believe the drugs are also appropriate treatments for viral infections such as the common cold. Find out how America scored on the "Antibiotics IQ" Test. Tue, 13 Nov 2012 12:35:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899429998&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=America Gets Mixed Score on ''Antibiotics IQ'' Test&WT.z_contenttype=PressRelease An editorial in the Washington Post highlights the risks of a "post-antibiotic era" and the promise of recent incentives to develop new antibiotics. Wed, 11 Jul 2012 16:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899404451&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=Editorial: Resistance to Antibiotics is Becoming a Crisis&WT.z_contenttype=NewsArticle A statement by Allan Coukell, director of medical programs at Pew Health Group, about the enactment of the Food and Drug Administration Safety and Innovation Act. Mon, 09 Jul 2012 15:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899403834&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=Pew Applauds Enactment of User Fee Legislation, Urges Its Swift Implementation&WT.z_contenttype=PressRelease An opinion editorial by Rebecca W. Rimel, president and chief executive officer of The Pew Charitable Trusts, highlights recent steps taken by regulators, lawmakers, businesses and health professionals to thwart 'superbugs' and develop new antibiotics. Sun, 01 Jul 2012 18:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899402328&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=Next Steps to Thwart 'Superbugs'&WT.z_contenttype=OpinionEditorial In an article about Senate passage of the FDA user fee bill, the Associated Press quotes Allan Coukell, director of medical programs at Pew Health Group, on the significance of the foreign drug manufacturing facility inspection provisions in the bill. Wed, 27 Jun 2012 08:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899401633&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=FDA User Fee Bill Gives Agency New Powers to Inspect Overseas Prescription Drug Plants&WT.z_contenttype=NewsArticle The U.S. Senate today joined the House in passing Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the U.S. Food and Drug Administration’s drug and device reviews. Tue, 26 Jun 2012 20:00:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899401007&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=Pew Commends U.S. Congress for Passing FDA User Fee Legislation&WT.z_contenttype=PressRelease A blog post in The Hill about the passage of legislation by the House that reauthorizes the FDA's user-fee program for brand-name drugs and medical devices and also expands the program. Thu, 21 Jun 2012 10:30:00 GMT http://www.pewtrusts.org/news_room_detail.aspx?id=85899400334&WT.rss_ev=f&WT.rss_f=Antibiotics and Innovation&WT.rss_a=House Cheers, Approves FDA Reform Bill&WT.z_contenttype=NewsArticle Terms and Conditions Page http://www.pewtrusts.org/terms_and_conditions.aspx